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Dear participants, 
We are honoured and pleased to welcome you to the EFOMP Medical 
Physics Short Course in Ljubljana. 
Medical physics in diagnostics, nuclear medicine and therapy using 
ionising radiation, as well as in new modalities like MRI are growing in 
importance every day. Although the role of medical physics is not the 
same in all European countries, we are convinced that, without the sup­
port of physicists, medicine would lack quality and new developments. 
The main objective of EFOMP is to harmonise and promote the best prac­
tice oj medical physics in Europe, to keep our profession on a high level 
and to establish new standards with regard to new developments. We 
hope, that this course will contribute to the improvement of your knowl­
edge and skills. 
Sophisticated techniques and new developments demand a profound 
knowledge in various fields of medical physics. Our explicit commitment 
should always be to spread this knowledge among and share it with col­
leagues all over Europe, and to ensure that all borders will be open to 
medical physics now. We hope our course will enrich your knowledge. At 
the same, this event is a unique opportunity to discuss medical physics 
issues of specific interest and significance and to make new friendships! 
We wish you a pleasant and memorable stay in Ljubljana. 
Božidar Casar 
Werner Schmidt 
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QA in Mammography1
A. Noel
Centre Alexis Vautrin Medica! Physics Department, Nancy, France 
The success of mammography especially for screening depends on the production 
of high-quality low-dose images. Production of such images is a complex and difficult 
task. 
A French Committee, known as G.I.M., consisting of Radiologists, Medical Physi­
cists, Bio-medical Engineer interested in mammography have formulated recommen­
dations for the Quality Control of the Technical Aspects of Mammography Screening. 
In order to ensure that high-quality low-dose mammography images are produced 
consistently, thus providing the best images possible for a dose »as low as reasonably 
achievable«, it is essential to set-up a quality control programme at each mammogra­
phy site. The quality of technical aspects and their measurements are defined. The 
recommendations give a detailed description of the quality control tests which should 
be carried out and include acceptance limits for each technical parameter. The fre­
quency of each test is clearly stated. Furthermore responsibilities of the Radiologist, 
the Technologist and the Medical Physicist are stated. 
An active quality control programme will minimise but not completely eliminate 
problems. It should be stressed that quality is a philosophy and should be continuous. 
That is why radiologist and technologist must look at every film with quality control in 
mind. The recommendations formulated here are applicable to all mammography 
units. 
1 Recommandations du Groupe Interdisciplinaire de Mammographie (G.l.M.) sur l'assurance de qualite en 
mammographie. 
H. BOUHNIK, l. DESQUERRE-AUFORT, A. NOEL, J. STINES
Rev. Im. Med. (1994) 6 : 447-454 
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Optimisation of protection 
in interventional radiology 
R. Padovani, G. Bernardi, A. Peterzol, E. Quai
S. Maria Hospital, Udine, ltaly
Interventional cardiology (IC) procedures are the most frequent invasive radiolog­
ical procedures and they have the potential for high patient and staff exposure; the 
largest number of reported patient skin injuries are from IC due, both, to the highest 
number of procedures performed and to the fact that they are mainly performed by 
cardiologists, with, in general, not sufficient knowledge of imaging technology and 
related radiation protection aspects. 
Influence on patient and staff doses of technical and methodological parameters 
adopted are presented. 
Typical patient and staff doses and maximum skin doses in IC procedures are dis­
cussed. Reference levels can represent an useful tool for exposure optimisation; meth­
odologies, to extend the concept from simple to complex procedures, are discussed. 
Reference levels, in term of dosimetric and technical quantities, can be correlated with 
the procedures complexity; the proposed method and the results from DIMOND con­
sortium are presented. 
For the purpose to prevent deterministic injuries, the maximum skin dose must be 
assessed for patients submitted to long, complex and/ or repeated procedures or when 
the threshold for deterministic effects can be exceeded. Dosimetric methods for on­
line dose estimation are presented. The need and convenience to adopt a trigger level 
for each complex procedure type and x-ray room is discusses. 
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Targeted nuclear medicine therapy 
A. Perkins
Academic Medica! Physics University of Nottingham, UK 
One of the unique strengths of nuclear medicine lies in the use of radiopharmaceuti­
cals for both diagnosis and therapy. Since the first introduction ofl-131 for therapy there 
has been a steady growth in the use of radionuclides for therapeutic use. The specificity 
of iodine uptake ([I-131 ]sodi um iodide) for thyroid tissue has resulted in its continued 
application for the treatment of functioning thyroid carcinoma and thyrotoxicosis. Oth­
er conditions have been treated by either intravenous injection for example P-32 for 
polycythaemia or intracavitary injection, for example [Y-90]colloid for synoviorthesis. 
We are now witnessing the production of new radiopharmaceutical formulations 
aimed at specific molecular targets. These in dude the specific processes of metabolic 
trapping, enzyme inhibition, receptor binding and antibody-antigen binding. Radiop­
harmaceuticals like [I-131 ]MIBG, [R-186]HDP and [Sm-153]EDMP are now well es­
tablished therapeutic agents. In addition new radiotherapeutic agents are being devel­
oped such as those based on somatostatin receptors and monoclonal antibodies. One 
particular challenge for the Medical Physicist is the application of the most appropri­
ate radionuclide for targeted therapy. The choice of therapeutic nuclide increasing and 
will depend upon matching the physical characteristics with the pharmacokinetics of 
the targeting moiety. Some examples of therapeutic nuclides are given below. 
Nuclide T1/2 emission maximum path length in tissue 
I-125 60.0d auger ->10nm 
At-211 7.2h alpha --> 65nm 
Cu-67 2.58d beta/gamma ------> 2.2mm 
I-131 8.04d beta/gamma -------> 2.4mm 
Sm-153 1.95d beta/gamma --------> 3.0mm 
Re-188 17.0h beta/gamma > 5.0mm
P-32 14.3d beta > 8.7mm
Y-90 2.67 beta > 12mm
The importance of the appropriate design of these agents cannot be over empha­
sised, since a sustained hit-on-the-target will lead to effective targeted therapy. 
ACP/05/02 
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A dedicated cyclotron center 
for PET radiopharmaceuticals: 
One year operational experience and 
recent developments for the future 
D. W. Becker
ARGOSZyklotron Betriebs-Ges.m.b.H. Klagenfurt, Austria 
The positron emission tomography (PET) is an unique, noninvasive, powerful di­
agnostic tool at the forefront of modem functional imaging in clinical nuclear medi­
cine. Due to the quantitative measurement of the local and tempo ral distributions of 
the radiopharmaceutical the PET is capable of providing images ofbiological process­
es and physiological situations instead of mere anatomy. N owadays it is widely estab­
lished as a routine assessment of cancer, neurological disorders and coronary artery 
disease in humans. And the diagnostic fields are rapidly growing with the development 
of new bio-tracers and new positron emitting radioisotopes. 
Traditionally PET is based on short-lived positron emitters (11C, 13N, 150, 18F) 
which are produced by low-energy cyclotrons. Due to the short half-live fast technical 
and chemical processes are essential for the production and the synthesis of the radiop­
harmaceuticals. Also highly optimised logistics are necessary until their applications 
in a PET center. 
The radionuclide 18F, mostly in the form of [18F]FDG, is suitable for long-distance 
distribution. The half-live of 109 min, fast synthesis times and high yields allow trans­
portation of multiple dose vials over a 6 hours tirne gap. This gives the possibility to 
operate a cyclotron center on a commercial base and distribute PET radiopharmaceu­
ticals to hospitals and private doctors over a certain distance. 
This talk will give an overview of the installation and the routine operation of the 
ARGOS cyclotron center dedicated for the production and distribution of different 
PET radiopharmaceuticals for in house use (LKH Klagenfurt) and the European mar­
ket. It will reflect the problems of the daily production and the logistical efforts. Final­
ly there will be an introduction of some new PET tracers of the second gen era ti on and 
new radioisotopes. 
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The role of EFOMP in maintaining 
the standards and status of 
Medical Physicists in Europe 
P. P. Dendy 
Introduction 
There have been several important developments in the education and training of 
medical physicists in the past 10-15 years and the 1997 Directive from the European 
Union on the health protection of individuals against the dangers of ionising radia ti on 
in relation to medical exposures will stimulate further changes. 
This presentation will look back at what has been achieved and try to anticipate the 
future. It draws heavily on the work of the European Federation of Organisations for 
Medical Physics (EFOMP) but the views expressed are my own. 
Medica! Physicists - are we fit for purpose? 
Two basic questions will be posed. What are the requirements of the employer? 
What are the expectations of the employee?. 
The major duties and responsibilities of a scientist in health care will be considered 
in some detail. From the point of view of the individual employee, the principal re­
quirements are:- a need for clear information and advice on recruitment and entry 
qualifications, a basic training programme, higher training and continuing education. 
To meet the above needs a medica! physicist requires 
• A knowledge base
• A skills base (competencies)
• A means ofkeeping up-to-date
All the above have to be set up in a way that they can be properly assessed and accredited. 
The role of EFOMP 
Embedded in the EFOMP Constitution is a clear commitment to propose guidelines for 
education, training and accreditation programmes. The EFOMP policy on medical physics 
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education and training was first set out in 1984 and the fundamental p1inciples have changed 
little since that tirne. One major development has been the formulation of a competency­
based format for the more practical aspects of training in radiotherapy, nuclear medicine 
and diagnostic radiology. Five levels of competency have been proposed and examples will 
be given of the knowledge, skill and experience required at each level. 
Implications of Directive 97 / 43 Euratom 
This Directive has important implications for medical physicists. There is a new 
definition of a »Medical Physics Expert« and in the future the employer will look to the 
MPE to engage in a much wider role. To recognise this wider role, EFOMP has updated 
its policy statement on the MPE and the key features will be presented. 
Medica! Physicists - are we all working 
to the same standards? 
It is extremely important to address this question because: 
• Many decisions of medical physicists have a direct consequence for patients
• Freedom of movement of medical physicists in Europe requires comparable
standards
• If we fail to work to the same standards we lose credibility (status).
Information will be given on the advice provided to National Member Organisa­
tions for setting up Registration Schemes and the current position on Registration 
Schemes in Europe will be presented. 
Finally there will be brief reference to the work of the EFOMP Standing Committee 
on Registration, with comment on some important current topics including a) Further 
thoughts on Continuing Professional Development Schemes; b) MPE Staffing shortag­
es in departments of diagnostic radiology; c) Proposals for setting up a »European 
Medica} Physicist« diploma. 
Conclusions 
1. EFOMP has more than 18 years experience in providing advice on a co-ordinat­
ed programme of education and training in medical physics
2. The EU Directive of 1997 on health protection against the dangers of medical
exposures of ionising radia ti on has substantially widened the role of the medi­
ca} physics expert
3. The important question - »Are medica} physicists trained in such a way that
they are fit for purpose and competent to practice?« - must be kept to the fare­
front
4. »Are medical physicists all working to the same standards in the different
EFOMP countries?« - is then an important supplementary
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ESTRO-EQUAL radiotherapy dosimetry audit 
for high energy photon and electron beams 
D. Georg,
Div. Medica! Radiation Physics, Dept. Radiotherapy and Radiobiology, AKH Vienna 
l. H. Ferreira1 , A. Dutreix1 , A. Bridier1 and H. Svensson2
Since 1998 the European Society for Therapeutic Radiology and Oncology (ES­
TRO) has set up a TLD Quality assurance programme (EQUAL) with the Physics De­
partment of the Institut Gustave Roussy (IGR, Villejuif, France) as measuring laborato­
ry. The traceability of the dose calibration to the BIPM (Bureau International des Poids 
et Mesures) is assured through periodical reference chamber calibrations at the French 
Primary Laboratory and annual intercomparisons with the IAEA/WHO network and 
other TLD networks and SSDL (Secondary Standard Dosimetry Laboratories). 
Till February 2002 more than 55% of all 800 European radiotherapy centres have 
participated in the EQUAL audit. This TLD postal dose assurance service addresses 
photon and electron beam checks in reference and non-reference conditions and is 
successful with more than 440 radiotherapy centres and 1500 beams checked. In the 
EQUAL programme, the accuracy in dose is checked on the central beam axis in refer­
ence and non-reference conditions. 
The EQUAL program started with photon beam audits checking the following four 
dosimetric parameters: the reference beam output (RBO), the percentage depth doses 
(PDD), the beam output variation (BOV) for open and wedged fields and the wedge 
transmission factor (WTF). Considering the EQUAL experience and the request from 
radiotherapy centres the programme was extended to include electron beam checks. 
The electron external audits covered by the network are also based on measurements 
made with mailed thermoluminescent dosimeters (TLD). The purpose of the electron 
TLD audit is to check the beam output for different field sizes. For each energy, 4 
electron beam output checks must be performed with the following field sizes: 10 cm x 
10 cm; 15 cm x 20 cm and 7 cm x 7 cm. 
Since EQUAL started its services dosimetric problems in the beam calibration, 
errors in beam data used as input to the treatment planning system (TPS), and in the 
1 ESTRO-EQUAL Measuring Laboratory, Service de Physique, Institut Gustave-Roussy, 94805 Villejuif, 
France. 
2 Radiation Physics Department, University of Umea, 90185 Umea, Sweden. 
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algorithms used in the TPS could be detected and corrected. The obtained results 
stimulated the interest of ESTRO and of the participating radiotherapy centres to start 
a new task. Considering the increasing number of treatment units using Multileaf Col­
limators (MLC) in European Radiotherapy centres, the EQUAL programme was ex­
tended to include dose checks in photon MLC fields on axis. The purpose of the new 
TLD audits is to check dosimetric data for fields tailored by a MLC as used for patient 
treatments. The dose at reference depth is checked for six fields in this protocol: the 
reference field (10 cm x 10 cm) and five other fields with shapes and dimensions 
defined by the MLC. In a next step the program is extended to cover as well open and 
wedged asymmetric beams. Currently a modified TLD holder is investigated offering 
possibilities for off-axis measurements. 
All services provided by EQUAL are supported by the European Commission ('Eu­
rope against Cancer programme') and are free of charge and available to all European 
countries. A memorandum of understanding has been signed with the IAEA and the 
service can be offered to the neighbouring countries, in agreement with IAEA, when 
there are no national possibilities. 
For more information contact the EQUAL secretary: Mrs. Aline Mechet; ESTRO­
EQUAL Secretariat; IGR Physics Department, 39 Rue Camille Desmoulins; F-94805 
Villejuif cedex, France, Fax +33/1/42.11.52.99, Tel: +33/1/42.11.50.50; e-mail: 
equal@igr.fr, or see web: www.estro.be. 
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The most important goal in radiation oncology is to give as much dose to the 
tumour as is reguired to kill the tumour cells while applying as a low dose as possible 
to the surrounding tissue as is possible to avoid complica-tions. For this reason modem 
treatment planning systems are used to calculate the irradiation for the individual 
patient anatomy. The patient is scanned with a x-ray CT-scanner so that a three dimen­
sional model of anatomy can be created with the treatment planning system. At the end 
of the treatment planning process the location of all treatment fields according to this 
computer model of the patient is fixed. 
Any »simulation« in radiation oncology has to do the following tasks: The coordi­
nates of the radia ti on fields have to be transferred from the 3D computer model to the 
living patient. Marks have to be drawn on the patient to enable a correct positioning of 
the patient at the treatment machine. The »simulation« is also used to create reference 
images of the patient anatomy from th� direction of the radia ti on fields (»beam's eye 
view images«). These images can be used for a comparison with images that are taken at 
the treatment machine to verify the correct positioning of the patients during the 
irradiation. 
Conventional simulation 
For the »conventional simulation« a special x-ray device called a »simulator« is used 
to check the proper align-ment of the patient. Usually bony landmarks of the patient 
are reference coordinates to set up the position of the radiation fields. Fluoroscopic 
images of the patient are taken until the moveable couch of the simulator is in the 
correct position. After this the position of the central axis and the shape of the radiation 
fields can be marked on the patient's skin. There is no direct link between the 3D patient 
model in the treatment planning system and the position of the patient on the simula­
tor table. The simulator is also used to create x-ray »simulation images« from the 
beam's eye view. 
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Virtual Simulation 
The virtual simulation process that I am going to describe is a mixture of what I have 
learned at the Department of Radiation Oncology, Washington University School of 
Medicine, St. Louis, Missouri (USA) and what is being implemented in my clinic, the 
University Hospital Hamburg-Eppendorf (UKE, Germany), right now. So far there is 
no standard definition for what is meant by »virtual simulation«. In this document I 
would like to define it as follows: 
The virtual simulation is 
• a series of steps
• and methods for quality assurance
• with the goal to simplify the »conventional simulation«
• or to replace the »conventional simulation« by other procedures
• and with the aim to get a higher precision at the application of the radia ti on
fields.
Hardware requirements 
A powerful CT scanner is needed to create a predse model of the patient anatomy 
within the treatment planning system [Mut02]. A CT scan with a spacing of two or three 
millimetres may be required [Pur99]. Small markers have to be used to define refer­
ence coordinates that are visible on the patient's skin and also in the CT images. To get 
the same alignment of the patient on the CT couch and on the treatment table an index 
patient positioning system has to be used. For this purpose patient fixation devices like 
thermoplastic head masks and alpha-cradles or vacuum cushions have to used as well. 
A system of moveable lasers is required for the patient set up at the CT scanner. Such a 
system can be used to mark the central axes and also the shape of the radiation fields. 
For the verification of the patient alignment at the treatment machine special projec­
tion plates have to be used that can indica te the position of the central axis in the portal 
images. Portal films that are very sensitive to radiation have to be used to allow double 
exposure images with a minimum <lose. 
Software requirements 
For the virtual simulation a treatment planning system is required that allows the 
calculation of beam's eye view images in high quality. The quality of these images has 
to be good enough to replace the x-ray images that are taken at a conventional simula­
tor. For this reason the treatment planning system has to be able to handle a large 
number of CT slices. Up to 200 images may be required for each patient. The treatment 
planning system will also have to calculate the coordinates of the central axes or the 
corners of the radiation fields in relation to the markers that have been used as refer­
ence points for the CT scan. Most advanced treatment planning systems will also gen­
erate coordinate-files that can be used to mark the position and the shape of the radia­
tion fields on the patients skin with a computer controlled laser marking system. 
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Virtual Simulation Setup at the University Hospital 
Hamburg-Eppendorf (UKE) 
At the UKE a Siemens Somatom Emotion® CT-scanner is used for the virtual sim­
ulation (»CT simulator«). The tube of this single slice scanner can spin with a speed up 
to 0.8 s per rotation and has a maximum acquisition tirne of 100 s without tube cooling. 
A carbon fibre couch top from MedTec® with an index patient positioning system is 
mounted at this scanner. The patients are irradiated with a Siemens Primus® linear 
accelerator that has also a MedTec® carbon fibre couch top with the same index posi­
tioning system. Vacuum cushions, alpha cra-dles, and head mask systems can be index 
on the tables with the MedTec lock bar®. With this system the patient fixation devices 
are always in the same position on the couch. 
The CT simulator is equipped with the LAP IsoMark® system which has five line 
lasers. With a manual or PC control each of them can be moved forward and backward 
in one direction. Two lasers, left and right of the couch, can move upward and down­
ward. Two lasers which are mounted left and right of the patient on the ceil-ing of the 
room can simultaneously move in the longitudinal direction. One laser, that is also 
mounted on the ceiling, can travel from the left to the right side of the patient. With this 
laser system any coordinate on the pa-tient skin can be marked with a cross produced 
by two lasers within their moving range. 
The treatment planning system CMS Focus 3.2.1 ® is used to create the treatment 
plans, to calculate the coordi-nates for the virtual simulation and to generate high 
resolution beam's eye view images (digitally reconstructed radiographs: DRR). CMS 
Focus can also produce ASCII-files that are transferred over the network to control the 
LAP IsoMark system. 
For the Siemens linear accelerator a special plate of perspex has been constructed 
that can be inserted in the wedge holder. It is equipped with metal sticks with a diameter 
of 1 mm and a length of 6 mm that mark the posi-tion of the central axes in double 
exposure verification images and that define a scale in the images. 
Example: Prostate cancer 
Patients with prostate cancer can be immobilized by a vacuum bag or alpha cradle 
at the CT simulator that is indexed with a lock bar. Some reference points are marked 
on the patient's skin with a pen and »Beekley CT-spots«® that consist out of small metal 
balls that are visible in the CT-scan and can stick on the patient's skin. Three of them 
define a reference plane for all further calculations of the coordinates for patient setup. 
A CT scan with a spacing of 3 mm or 5 mm is taken to get high quality DRR. After the 
CT scan was executed the patient can leave the CT simulator and a treatment plan is 
generated with CMS Focus. The DRR calculated replaces the x-ray images that would 
be taken on a conventional simulator. 
For the virtual simulation the patients have to come back to the CT simulator. They 
are repositioned in their indexed vacuum bag or alpha cradle on the couch of the CT 
scanner. At least one reference scan has to be taken to make sure that the patient is in his 
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original position. The ASCII-file from CMS Focus for the LAP IsoMark system can be 
used now to project the central axes and contours of the radia ti on fields on the patient's 
skin. Corner by corner all contours can be marked with a pen on the patient's skin or the 
fixation devices. 
For all setups at the linear accelerator the index positioning system is used again. 
The marks on the patient's skin and the fixation devices are used to double check proper 
alignment of the pati en t. For the verification of the correct positioning of the patient 
during the irradiation double exposure images are taken that show the size and locali­
zation of the radiations field and the surrounding bony landmarks of the patient. In this 
case there is no more need for a conventional simulator. 
LITERATURE 
[Mut02] Mutic S, Palta JR, Butker EK et al. Quality assurance for CT simulators and for CT simulation 
process: Report of the AAPM Radiation Therapy Committee Task Group No. 66. draft 2.0 under discus­
sion, 2002. 
[Pur99] Purdy JA, Starkschall G. A practical guide to 3-D planning and conformal radiation therapy. Madi­
son, Wisconsin: Advanced Medica! Publishing, 1999. 
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The implementation of IMRT: 
The Leuven experience 
D. P. Huyskens, A. Van Esch
University Hospital of Leuven Department of Oncology Division of Radiation Physics 
Intensity Modulated Radiotherapy Treatments (IMRT) are performed at the radio­
therapy department of Leuven (Belgium, Europe) with a Varian Clinac 2100 C/D 
equipped with a dynamic MLC (80 leaves). Treatment planning is performed with the 
inverse planning modules Helios-Cadplan. Portal imaging and associated QA is done 
with the Portal Vision EPID and the associated Vision software environment. The Cad­
plan modules have also special Varian research software, the portal dose image predic­
tion algorithms. 
The following steps were performed/introduced to implement and validate IMRT 
treatments in the department: 
a) Commissioning/acceptance of the TPS:
Quality assurance of the treatment planning system (TPS) including the inverse
planning modules of Helios was performed using the multipurpose phantom. The 
system was tested under extreme conditions, e.g. three different doses at a fixed depth, 
three identical doses at different depths. Dose distributions calculated by the treatment 
planning system were compared to dose distributions measured with film dosimetry. 
From these tests it appeared that the shape of the kernel introduced in Cadplan was very 
important to obtain good agreements between predicted and measured dose distribu­
tions. 
Secondly the use of artificially created plans offered the possibility to assess the 
specific values of some MLC parameters such as leaf transmission and dosimetric leaf 
separation. Their impact is much more important for dynamic than for static beams 
( e.g. leaf transmission, dosimetric leaf separation, etc ... ). 
b) QA of the dynamic MLC:
QA of the dynamic MLC was performed following the protocol developed at Me­
morial (Chui et al., LoSasso et al., etc.). These tests include the 'garden fence' test and 
the routine dosimetric check of position of the central leaf pairs. It is worthwhile to 
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men ti on that for the QA of the DMLC the electronic portal imaging device is extensive­
ly used, reducing considerably the workload compared to film evaluation. 
c) Pre-treatment veri.fication of IMRT treatments (patient-speci.fic QA):
For the first cohort of patients treated with IMRT for a given treatment site, individ­
ual fields were checked by film dosimetry in a phantom. To do so, Helios supports the 
transfer of individual patient fluences onto a phantom. The <lose distribution, recalcu­
lated in the phantom, can be exported for comparison with e.g. film measurement. 
Absolute <lose measurements were performed by ionisation chamber measurements 
in the same phantom. In a second step these time consuming phantom measurements 
were replaced by a comparison between dosimetric images acquired with the EPID and 
the <lose distributions predicted by the treatment planning system at the level of the 
imager. By doing so the time needed to check e.g. a five field IMRT plan could be 
reduced from about 5 hours to about half an hour (in optimal conditions). 
As a conclusion the implementation of IMRT at the radiotherapy department of 
Leuven was a smooth process because of the existence of the appropriate tools for QA 
at the patient level: Helios export tools, EPID dosimetry in dynamic mode and portal 
<lose prediction algorithms. 
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IMRT - from research to routine 
W. F. O. Schmidt1 ; W. Nespor; K. Pavlas; R. Hawliczek 
Institute for Radiooncology, Donauspital Vienna 
In spring 2002 in Vienna IMRT is performed already in 3 departments with differ­
ent linacs and planning systems (VARIAN/HELIOS, ELEKTA/HELAX, SIEMENS/ 
CORVUS); a fourth planning system (CMS, Donauspital Vienna) is starting to get into 
routine. Also in a fourth department IMRT with compensators is in preparation (SIE­
MENS/PLATO). So it is possible to compare how the different planning systems work, 
how to integrate them into routine and to take a look into different requirements and 
developments. 
The first step (linac and planning system technical setups for IMRT) has become 
routine meanwhile. Also production and verification of compensators seems to be 
possible with 3D cuuting devices and film dosimetry (after some important develop­
ments in image comparison). More problems arise from verficiation measurements 
(for planning systems and for patients). No standard for phantoms and measurement 
devices has been established yet. Also comparison of measurement and planning is 
different, examples shall be presented in a short overview. Still it is important to be 
aware, that IMRT-verification is not completely independent from planning systems. 
Up to now it is not possible to »compare« plans from different planning systems 
simply. In routine eg <lose prescription to target volumes, under-/ overdosage of critical 
organs and their weighting are different and strongly influence results. Point- or line­
doses, DVHs or other planning criteria are not enough for treatment decisions; also 
overall treatment tirne, tirne efforts for verification, safety criteria etc may contribute. 
But the main challenge is coworking of physicians, technicians and physicists. 
Design of target volumes including safety margins, <lose escalation (with respect to 
radiobiology), validity of ICRUS0/62 criteria and scatter doses to regions outside the 
target vol ume and the whole body have to be taken into account and may influence 
treatment indications and schedules. 
So there is still some work to do to get IMRT into routine .... 
1 werner.schmidt@smz.magwien.gv.at 
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The use of an EPID for QA of IMRT 
A. Van Esch, D.P. Huyskens
University Hospital of Leuven Department of Oncology Division of Radiation Physics 
The Radiotherapy department of the University Hospital of Leuven (Belgium) is 
equipped with a Varian Electronic Portal Imaging Device (originally a liquid filled 
MarkII EPID, later on replaced by an amorphous silicon EPID) for dosimetry ofIMRT. 
The software to support EPID dosimetry of IMRT fields consists of the Dosimetric 
Workspace (V ision, Varian Medical Systems) and a portal <lose image prediction soft­
ware (Cadplan, Varian Medical Systems). 
a) Dosimetric aspects of the EPID in dynamic mode:
Varian has developed a special acquisition mode for acquiring IMRT dosimetric
images. The mode is a fast acquisition mode, unsynchronised to the linac pulses. Basic 
corrections perfonned by the system are dar k field corrections ( electrometer offset) 
and flat field corrections (sensitivity variation). A dedicated module is integrated in 
the dosimetric workspace to calibrate the EPID for dosimetry. The assessment of the 
possibility to use the EPID in dosimetric mode was performed by comparison to ion­
isation chamber measurements and film dosimetry. The reproducibility of the EPID 
was excellent while the remanence effect (ghosting effect) turned out to be negligible. 
b) Portal dose image prediction:
The portal <lose prediction algorithms implemented in Cadplan are based on the
algorithms developed by the Rotterdam group (Pasma et al., M. de Langen et al.). For 
each field it is possible to predict the <lose distribution at the level of the electronic 
portal imaging device, either with patient or without patient in the beam. This module 
has been used to compare predicted images and acquired images (without patient); in 
a first step these modules were used for relative dosimetry ( default normalisation to 
<lata point on the beam axis); however, this relative dosimetry still requires additional 
measurements of absolute <lose (point <lose measurements). Since point <lose measure­
ments may report artificially large discrepancies in large gradient regions, the EPID 
system was further developed to measure <lose in absolute mode. 
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c) Pre-treatment in clinical routine:
Basic appropriate tools have been developed in the Vision environment to compare
dosimetric image and portal dose prediction (isodose overlays, line profiles, image 
substraction etc.). It soon became apparent that there was a need for additional effi­
cient and overall verification of 2-D distributions. Based on the work performed by 
Low et al, the gamma evaluation method - using a combination of dose differences and 
distance to agreement - was further refined to compare dosimetric images. The gamma 
algorithm was used to compare dosimetric images with portal dose predictions, dosi­
metric images of different treatment fractions and to evaluate error detection possibil­
ities. Future tools will need to combine isodose overlays, profile measurements and 
gamma evaluations. 
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Austrian Society for Medical Physics 
Osterreichische gesellschaft fiir medizinische physik (OGMP) 
W. F. O. Schmidt 
Institute tor Radiooncology, Donauspital Vienna 
CURRENT STATUS: 
~170 members (among them ~10 companies) 
President: H. Leitner, Graz 
Vice-President: H. Mandl, Salzburg 
Secretary: G. Stuecklschweiger, Graz 
Treasurer: R. Freund, Vienna 
Homepage: www.oegmp.at 
Members & main activities: 
The OGMP was founded in 1980. Approximately 50% of its members work in 
hospitals, 60% of them in radiotherapy departments (12 centres with ~ 40 high-voltage 
machines), the others in nuclear medicine, radiology and various medical depart­
ments. 25% of the members work in research ( universities and research institu-tions in 
Vienna, Graz and Innsbruck), 8% in departments for radiation safety , 15% for compa­
nies or government and 2% others. 
The OGMP has a contact group with the OPG (Austrian Physics Society). Contacts 
are also established to the Society for Biomedical Techniques (OGBMT), to the Radia­
tion Protection Societies (VMSO, OVS) and to Medical Societies like OGRO 
(Radio-Oncology), ONG (Nuclear Medi-dne) 
and ORG (Radiology). 
The OGMP works closely together with the German and Swiss Medical Physics 
Societies and is member of the EFOMP and IOMP. The yearly meeting is often com­
bined with other physics' or medical societies. Normally two one-day work-shops per 
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Also in collaboration with the G erman and Swiss Societies ofMedical Physics the 
journal «Zeitschrift fur Medizinische Physik« is published quarterly and a 2-week teach­
ing course («Winterschule«) for continuing education of the members is organized 
every year. 
Special features 
Since 1989 the University of Vienna and the OGMP offer a 3-year postgraduate 
»medica! physics course«. Since 2001 the OGMP title «medica! physicist«, according to
the EFOMP regulations, is officially recognized by the ministry of health. The new
draft of the radiation protection law mentions specifically the «medica} physi-cist« as
fulfilling the requirements of the »medical physics expert« defined by 97 /43/EURATOM.
At present appr. 50 physicists are qualified according to this directive. Therefore it is
an important duty of the OGMP to control the requirements of qualification. In gener­
al, the OGMP is recognised by the Austrian government as a competent address for all
matters of physics as applied to medicine.
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Medical physics in France 
H. Bouscayrol, S. Naudy, A. Noel,
on behalf of the French Society of Medical Physics (SFPM) 
The medical physicist profession started in France when physicists were involved 
for the first tirne in the use of radiation for medical purpose mainly in radiotherapy 
departments, that was in 1950. Then the appointment of a full tirne physicist became 
mandatory, through a ministerial authorisation in 1969, in departments where a linear 
accelerator of E> 1.5 MV RX was in use. The following year the Diploma of Advanced 
Studies in Radiation Physics (DEA- 5th year university) was created at the Toulouse 
University and so the medical physicist profession became official. In 1972 a bunch of 
professionals created the French Society of Medical Physics (actual name) ... Thirty 
years later over 300 medical physicists work mainly in the ionising radiation area in 
180 centres (puhlic, private or cancer dedicated) over the whole country. The educa­
tion programme has naturally evolved. A one year on-site training based on Efomp 
recommendations is now required in addition to the DEA. The 20-25 students per year 
are expected to get introduced to the professional practice in the four major fields: 
radiotherapy, radiology, nuclear medicine and radiation protection including compul­
sory routine tasks within the 21 certified medical physics departments. The area of 
involvement has spread. The nuclear medicine departments are now required to em­
ploy at least part-time medical physicists (ministerial order of 1977) and the diagnos­
tic radiology departments are starting to seek for the expertise of those professionals 
while still expecting the application of the European directive Euratom/97 / 43. The 
involvement of the medical physicists and the mean tirne really spent among the differ­
ent area is as follow (SFPM 98 survey, more than 1 answer possible): 
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Furthermore the professionals are engaged in the promotion of their qualification 
and competence through continuing education. The Society set up a Register fully 
approved by Efomp since 2001 but not yet recognised by the national authorities. 
The need for medica! physicists is currently growing in France as the implementa­
tion of the directive 97 /43 assert the dose delivered to the patient in any radiation 
based diagnostic procedure as one of the major concern. The education system will 
have to provide an increased number of students while maintaining a good quality 
programme. 
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Medical physics in Denmark: 
Education and employment 
K. Olsen,
Dept. of Radiation Physics, University Hospital of Herlev, Denmark 
J. Carl
Oept. Radiation Physics, University Hospital of Aalborg, Denmark 
Medical physics has a long history in Denmark. The use of radioactive sources for 
brachytherapy necessitated already around 1920 the service of physicists for calibra­
tion of the output. 
In 1954 the first department for radiation physics was established at the Finsen Hos­
pital in Copenhagen followed similar departments at the other radiotherapy centres. 
Legal demands for the service of medical physicists came into force in 1991 with 
the laws on the medical use of accelerators for patient treatments. In this law the 
qualification and responsibility of the physicists were specified. A law on the use of 
closed radioactive sources for brachytherapy came in 1995. 
The European Union directive on patient protection in 1997 necessitated new national 
legislation in 2000.This covered diagnostic radiology, nuclear medicine and radiotherapy. 
The Danish Society of Medical physics was founded in 1982.A scheme for educa­
tion and training of medical physicists for radiotherapy was the first major task. That 
was completed in 1985. 
It was based on a master degree in physics. Since there is little physics taught at 
university level in Denmark supplementary courses in radiation physics and training 
were given while the physicists were employed at a radiotherapy centre. Courses run 
by ESTRO and EFOMP have been used quite extensively. 
In 1995 a formal education scheme was agreed on with the Danish Board ofHealth. 
An education council under DSMF supervises education and training of all physicists 
and after successful completion of the scheme under the local responsibility of a qual­
ified physicist the council proposes to the Board ofHealth that the physicist be recog­
nised within the speciality chosen. 
The new requirements for physicists in diagnostic radiology and nuclear medicine 
have meant a large increase in the number of physicists in training in these areas. These 
physicists are ususally directly employed in the diagnostic departments. 
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Present position and education 
of medical physicists in Croatia 
M. Vrtar,
University Hospital Center Rebro, Zagreb 
T. Viculin
University Hospital forTumours, Zagreb 
The total number of medical physicists in Croatia amounts about 30. In radiother­
apy departments there are 18 and in nuclear medicine 6. Others are working in radia­
tion protection and health care activities in medical and research institutes. The number 
of inhabitants in Croatia is 4.5 millions. The hospitals are equipped with 7 linear 
accelerators, 6 cobalt units, 12 gamma cameras and 6 radiotherapy simulators. The 
medical physicists are organized as Division of the Croatian Medical and B iological 
Engineering Society (CROMBES), which is a member ofEFOMP. Until now, the educa­
tion consisted of the following: After the regular 4 years study of physics, the 2 years 
postgraduate education could be continued in medical physics. It resulted in a Master 
of Science level. This year we expect the acceptance of the new specialist study, which 
is formed according the EFOMP recommendations. It means that together with the 
theoretical lectures (as in scientifically direction), a 4 years practical in-the-job train­
ing should be released in clinical hospitals. The title after the final specialist exam 
should be the Mas ter of Medical Physics, Specialist. It is very important, because now 
the physicists are treated as non-medical workers. It results in degraded position in 
profession and in salary. 
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Society of medical physics and biophysics 
of the slovak medical society, Slovakia 
G. Kralik,
St. Elisabeth Cancer Institute, Bratislava, Slovakia 
V. Laginova
St. Elisabeth Cancer Institute, Bratislava, Slovakia 
The Society was established in 1976 as part of the Czechoslovak Medical Society as 
an association of physicists and biophysicists working in the field of protection against 
radiation. Its total membership included more than 100 members. After Czechoslova­
lda had been divided into the Czech Republic and Slovak Republic, the Society contin­
ued to exist only in Slovakia. At present it has 37 members. 
President of the Society: Professor Vit Šajter, PhD. 
Contact persons: RNDr. Soi"ia Kovačova, PhD., skovacov@ousa.sk 
RNDr. Gabriel Kralik, gkralik@ousa.sk 
Among the main tasks of the Society is the exchange of experience concerning the 
problems in physics, dosimetry, biology and radiation hygiene. Discussions held in 
these meetings made it possible to choose methodological approaches and their har­
monisation with European recommendations in agreement with the traditions started 
in 1981 when the first conference of physicists was held in Czechoslovakia also with 
the participation of internationally renowned specialists, among them e.g. also Profes­
sor John Clifton. 
This was the first opportunity to create personal contacts with colleagues from 
Western Europe that had a positive influence on further co-operation and on our ef­
forts to become a member of EFOMP. 
Since then the situation has changed and the members have the possibility to par­
ticipate in symposia and conferences not only in Slovakia but also abroad. 
In the Society there are physicists working mainly in the field of radiotherapy and 
nuclear medicine, and besides their routine work they focus also on introducing new 
techniques and their verification within respective research projects. 
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Unfortunately, at present no physicists do work in our country at radiology depart­
ments. This must be changed within short. 
A majority of the physicists work in government-owned hospitals. 
The members of the Society have close co-operation with SRTBF that is a member 
ofESTRO. Owing to this, we managed to participate in several international programs 
that have been co-ordinated by the Department of Clinical Radiation Physics at the St. 
Elisabeth Cancer Institute, Bratislava. 
At present we are a member ofthe SSDL network within IAEA and our task is the 
verification of clinical dosimeters from whole Slovakia. 
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Medical Physics in Slovenia 
B. Casar,
Institute of Oncology 
U. Zdešar
Institute of Occupational Safety 
In 1996 the medical physicists in Slovenia were organized in the Medical Physics 
Section of Slovenian Biophysical Society. As the number of physicists involved in 
medicine was small it was not reasonable to found our own society. At the present 
MPSSBS has 20 members, half of them working in a hospitals: 25 % of physicist work in 
radiotherapy, 35 % in diagnostics, nuclear medicine and radiation protection, the rest 
are involved in research work and governmental duties. As the Slovenia is very small 
· country, there is no special education program in the field of medical physics.
It is obvious, that the number of physicists involved in clinical work could not 
possibly cover all the duties which are required in modern clinical work. It is clear also 
if we look at the numbers of machines in hospitals in Slovenia: 
30 clasical X-ray machines 
96 X-ray machines with Image Intensifiers 
33 mobile X-ray machines 
30 Mammography X-ray machines 
17 CT machines 
5 MRI machines 
7 laboratories for nuclear medicine (2 of them for therapy) 
1 conventional simulator 
1 simulator with CT option 
1 CT for radiotherapy 
2 Co-60 machines 
3 linear accelerators 
Relatively poor situation in medical physics is largely a consequence of our old and 
unadequate legislation, but new legislation which follows the requirements from 
97 /43/EURATOM and other European documents is already layed down before our 
parliament and we expect to be accepted soon. 
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